Literature DB >> 20854919

Prolonged thrombocytopenia following allogeneic hematopoietic stem cell transplantation and its association with a reduction in ploidy and an immaturation of megakaryocytes.

Xiaohui Zhang1, Haixia Fu, Lanping Xu, Daihong Liu, Jianzhong Wang, Kaiyan Liu, Xiaojun Huang.   

Abstract

Prolonged thrombocytopenia is a frequent complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT); however, its pathogenesis has remained obscure. In the present study, we used flow cytometry to determine the frequency of bone marrow megakaryocytes (MKs) and MK ploidy distributions in allo-HSCT recipients with or without prolonged thrombocytopenia (n = 32 and 27, respectively) and healthy volunteers (n = 13). In addition, the expression of c-Mpl in MKs was measured. The results indicate that the proportions of MKs in marrow mononuclear cells or the percentages of CD110(+) MKs in total MKs did not significantly differ between the 3 groups; however, in a comparison of nonthrombocytopenic allo-HSCT recipients to healthy volunteers, the allo-HSCT patients who had prolonged thrombocytopenia exhibited significant shifts toward low ploidy cells (left shift), which were accompanied by a marked increase in ≤ 8N cells (P = .036 and P < .001, respectively) and significant decreases in 16N cells (P < .001 and P < .001, respectively) and ≥ 32N cells (P = .01 and P <.001, respectively). These results indicate that there were more immature MKs in allo-HSCT recipients who had prolonged thrombocytopenia, in comparison to nonthrombocytopenic allo-HSCT recipients and healthy volunteers. We conclude that prolonged thrombocytopenia and slow platelet engraftment after allo-HSCT may be related to a reduction in ploidy and an immaturation of MKs.
Copyright © 2011 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20854919     DOI: 10.1016/j.bbmt.2010.09.007

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  13 in total

Review 1.  Eltrombopag: Role in Cytopenias Following Hematopoietic Stem Cell Transplantation.

Authors:  Ram Vasudevan Nampoothiri; Rajat Kumar
Journal:  Indian J Hematol Blood Transfus       Date:  2019-09-24       Impact factor: 0.900

2.  Identification of anti-thrombopoietin receptor antibody in prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation treated successfully with eltrombopag.

Authors:  Akihito Fujimi; Yusuke Kamihara; Akari Hashimoto; Yuji Kanisawa; Chisa Nakajima; Naotaka Hayasaka; Shota Yamada; Toshinori Okuda; Shinya Minami; Kaoru Ono; Satoshi Iyama; Junji Kato
Journal:  Int J Hematol       Date:  2015-05-13       Impact factor: 2.490

3.  Eltrombopag in the treatment of patients with persistent thrombocytopenia after haploidentical peripheral blood stem cell transplantation: a single-center experience.

Authors:  Fei Yan; Ning Lu; Zhenyang Gu; Wenrong Huang; Shuhong Wang; Xiaoning Gao; Liping Dou; Fei Li; Lili Wang; Meng Li; Daihong Liu; Chunji Gao
Journal:  Ann Hematol       Date:  2021-11-04       Impact factor: 3.673

4.  Photobiomodulation and Antimicrobial Photodynamic Therapy for Oral Ulcers in a Patient With Thrombocytopenia Following Bone Marrow Transplantation.

Authors:  Luana Campos; Daniel Campanhã; Ricardo Yudi Tateno; Luiz Felipe Palma
Journal:  J Lasers Med Sci       Date:  2022-04-21

5.  Dysregulated megakaryocyte distribution associated with nestin+ mesenchymal stem cells in immune thrombocytopenia.

Authors:  Min Wang; Ru Feng; Jia-Min Zhang; Lin-Lin Xu; Fei-Er Feng; Chen-Cong Wang; Qian-Ming Wang; Xiao-Lu Zhu; Yun He; Jing Xue; Hai-Xia Fu; Meng Lv; Yuan Kong; Ying-Jun Chang; Lan-Ping Xu; Kai-Yan Liu; Xiao-Jun Huang; Xiao-Hui Zhang
Journal:  Blood Adv       Date:  2019-05-14

6.  Management of thrombocytopenia in a patient with a mechanical mitral valve undergoing autologous hematopoietic stem cell transplantation: case report and review of literature.

Authors:  Gregory Miller; Samuel B Reynolds; William W Tse
Journal:  Am J Blood Res       Date:  2020-02-15

7.  Recombinant human thrombopoietin promotes platelet engraftment after umbilical cord blood transplantation.

Authors:  Baolin Tang; Lulu Huang; Huilan Liu; Siqi Cheng; Kaidi Song; Xuhan Zhang; Wen Yao; Lijuan Ning; Xiang Wan; Guangyu Sun; Yun Wu; Jiehui Cheng; Qi Long; Zimin Sun; Xiaoyu Zhu
Journal:  Blood Adv       Date:  2020-08-25

8.  [Chinese expert consensus on the diagnosis and treatment of venous thromboembolism after hematopoietic stem cell transplantation (2022)].

Authors: 
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2022-03-14

9.  Pulmonary Infection Within 100 Days After Transplantation Impaired Platelet Recovery in Patients with Hematologic Malignancies: A Propensity-Score-Matched Analysis.

Authors:  Roujia Wang; Aijie Huang; Qi Chen; Libing Wang; Lei Gao; Huiying Qiu; Xiong Ni; Weiping Zhang; Jianmin Yang; Jianmin Wang; Xiaoxia Hu
Journal:  Ann Transplant       Date:  2019-09-27       Impact factor: 1.530

10.  Desialylation is associated with apoptosis and phagocytosis of platelets in patients with prolonged isolated thrombocytopenia after allo-HSCT.

Authors:  Xiao-Hui Zhang; Qian-Ming Wang; Jia-Min Zhang; Fei-Er Feng; Feng-Rong Wang; Huan Chen; Yuan-Yuan Zhang; Yu-Hong Chen; Wei Han; Lan-Ping Xu; Kai-Yan Liu; Xiao-Jun Huang
Journal:  J Hematol Oncol       Date:  2015-10-23       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.